Correlation Between Aptitude Software and Biotech Growth

Can any of the company-specific risk be diversified away by investing in both Aptitude Software and Biotech Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptitude Software and Biotech Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aptitude Software Group and The Biotech Growth, you can compare the effects of market volatilities on Aptitude Software and Biotech Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptitude Software with a short position of Biotech Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptitude Software and Biotech Growth.

Diversification Opportunities for Aptitude Software and Biotech Growth

0.25

Correlation Coefficient

Aptitude Software  Biotech Growth

Modest diversification

The 3 months correlation between Aptitude and Biotech is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Aptitude Software Group and The Biotech Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotech Growth and Aptitude Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptitude Software Group are associated (or correlated) with Biotech Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotech Growth has no effect on the direction of Aptitude Software i.e., Aptitude Software and Biotech Growth go up and down completely randomly.

Pair Corralation between Aptitude Software and Biotech Growth

Assuming the 90 days trading horizon Aptitude Software is expected to generate 2.8 times less return on investment than Biotech Growth. In addition to that, Aptitude Software is 1.41 times more volatile than The Biotech Growth. It trades about 0.04 of its total potential returns per unit of risk. The Biotech Growth is currently generating about 0.14 per unit of volatility. If you would invest  69,800  in The Biotech Growth on April 20, 2025 and sell it today you would earn a total of  11,000  from holding The Biotech Growth or generate 15.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aptitude Software Group  vs.  The Biotech Growth

Aptitude Software

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Aptitude Software Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Aptitude Software is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Biotech Growth

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in The Biotech Growth are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Biotech Growth unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aptitude Software and Biotech Growth

The main advantage of trading using opposite Aptitude Software and Biotech Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptitude Software position performs unexpectedly, Biotech Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotech Growth will offset losses from the drop in Biotech Growth's long position.

The idea behind Aptitude Software Group and The Biotech Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.